{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:29:36Z","timestamp":1773732576028,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002595","name":"American Otological Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.heares.2021.108202","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T06:14:05Z","timestamp":1613369645000},"page":"108202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A clinically derived guinea pig dosing model of cisplatin ototoxicity"],"prefix":"10.1016","volume":"404","author":[{"given":"James K.","family":"Stanford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7753-4076","authenticated-orcid":false,"given":"Nicholas A.","family":"Bosworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew S.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Spankovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heares.2021.108202_bib0001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CAD.0b013e32835739fd","article-title":"An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect","volume":"24","author":"Bielefeld","year":"2013","journal-title":"Anticancer Drugs"},{"issue":"5","key":"10.1016\/j.heares.2021.108202_bib0002","first-page":"700","article-title":"Differences in Ototoxicity across Species","volume":"37","author":"Blakley","year":"2008","journal-title":"J. Otolaryngol.-Head Neck Surg."},{"issue":"7","key":"10.1016\/j.heares.2021.108202_bib0003","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1038\/cddis.2017.314","article-title":"Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity","volume":"8","author":"Borse","year":"2017","journal-title":"Cell Death Dis"},{"issue":"102","key":"10.1016\/j.heares.2021.108202_bib0004","first-page":"47","article-title":"Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs?","volume":"144","author":"Cardinaal","year":"2000","journal-title":"Hear. Res."},{"issue":"4","key":"10.1016\/j.heares.2021.108202_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2014.04.123","article-title":"Rapamycin alleviates cisplatin-induced ototoxicity in vivo","volume":"448","author":"Fang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heares.2021.108202_bib0006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","article-title":"An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity","volume":"375","author":"Fernandez","year":"2019","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2021.108202_bib0007","series-title":"Guidance For industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials For Therapeutics in Adult Healthy Volunteers","first-page":"7","year":"2005"},{"key":"10.1016\/j.heares.2021.108202_bib0008","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/0929867054637626","article-title":"Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches","volume":"12","author":"Galanski","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"8","key":"10.1016\/j.heares.2021.108202_bib0009","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/CAD.0000000000000395","article-title":"Ototoxicity of 12mg\/kg cisplatin in the Fischer 344\/NHsd rat using multiple dosing strategies","volume":"27","author":"Harrison","year":"2016","journal-title":"Anticancer Drugs"},{"issue":"9","key":"10.1016\/j.heares.2021.108202_bib0010","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.fct.2011.05.017","article-title":"Possible role of cysteine-S-conjugate \u03b2-lyase in species differences in cisplatin nephrotoxicity","volume":"49","author":"Katayama","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.heares.2021.108202_bib0011","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/cncr.29779","article-title":"Ototoxicity and cancer therapy","volume":"122","author":"Landier","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.heares.2021.108202_bib0012","doi-asserted-by":"crossref","first-page":"229","DOI":"10.21037\/atm.2018.05.10","article-title":"Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined","volume":"6","author":"Le","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.heares.2021.108202_bib0014","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0194599814544877","article-title":"Targeted amelioration of cisplatin-induced ototoxicity in guinea pigs","volume":"151","author":"Mohan","year":"2014","journal-title":"Otolaryngol.-Head Neck Surg."},{"key":"10.1016\/j.heares.2021.108202_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2019.107780","article-title":"Repeated temporary threshold shift and changes in cochlear and neural function","volume":"381","author":"Morgan","year":"2019","journal-title":"Hear. Res."},{"issue":"3","key":"10.1016\/j.heares.2021.108202_bib0016","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/0194599811406673","article-title":"Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model","volume":"145","author":"Murphy","year":"2011","journal-title":"Otolaryngol.-Head Neck Surg."},{"issue":"5","key":"10.1016\/j.heares.2021.108202_bib0017","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1121\/1.5132711","article-title":"Use of the guinea pig in studies on the development and prevention of acquired sensorineural hearing loss, with an emphasis on noise","volume":"146","author":"Naert","year":"2019","journal-title":"J. Acoust. Soc. Am."},{"issue":"1","key":"10.1016\/j.heares.2021.108202_bib0018","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0194599815606704","article-title":"Cisplatin-induced ototoxicity and the effects of intratympanic diltiazem in a mouse model","volume":"154","author":"Naples","year":"2016","journal-title":"Otolaryngol.-Head Neck Surg."},{"issue":"2","key":"10.1016\/j.heares.2021.108202_bib0020","doi-asserted-by":"crossref","DOI":"10.5152\/iao.2016.1989","article-title":"Protective effect of Korean red ginseng on cisplatin ototoxicity: is it effective enough?","volume":"12","author":"Olgun","year":"2016","journal-title":"J. Int. Adv. Otol."},{"issue":"4","key":"10.1016\/j.heares.2021.108202_bib0021","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/SCS.0000000000000881","article-title":"Evaluation of the protective effect of \u03b1-lipoic acid on cisplatin ototoxicity using distortion-product otoacoustic emission measurements: an experimental animal study","volume":"25","author":"Ozkul","year":"2014","journal-title":"J. Craniofacial Surg."},{"key":"10.1016\/j.heares.2021.108202_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/523480","article-title":"Possible protective effect of sertraline against cisplatin-induced ototoxicity: an experimental study","author":"Ozturk","year":"2013","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.heares.2021.108202_bib0023","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12032-010-9477-4","article-title":"The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats","volume":"28","author":"Paksoy","year":"2011","journal-title":"Med. Oncol."},{"issue":"9","key":"10.1016\/j.heares.2021.108202_bib0024","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/MAO.0000000000001546","article-title":"Oral administration of clinical stage drug candidate SENS-401 effectively reduces cisplatin-induced hearing loss in rats","volume":"38","author":"Petremann","year":"2017","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.heares.2021.108202_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijporl.2019.03.021","article-title":"Prevention of cisplatin-induced hearing loss by extended release fluticasone propionate intracochlear implants","volume":"121","author":"Pierstorff","year":"2019","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"3","key":"10.1016\/j.heares.2021.108202_bib0026","first-page":"155","article-title":"A dose-effect study of cisplatin ototoxicity in albino guinea pigs","volume":"32","author":"Salehi","year":"2020","journal-title":"Iran J. Otorhinolaryngol."},{"issue":"7","key":"10.1016\/j.heares.2021.108202_bib0027","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/MAO.0000000000000403","article-title":"Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model","volume":"35","author":"Salehi","year":"2014","journal-title":"Otol. Neurotol."},{"issue":"1","key":"10.1016\/j.heares.2021.108202_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anl.2012.05.010","article-title":"Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs","volume":"40","author":"Shafik","year":"2013","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.heares.2021.108202_bib0029","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.heares.2015.11.009","article-title":"Assessment of thermal treatment via irrigation of external ear to reduce cisplatin-induced hearing loss","volume":"332","author":"Spankovich","year":"2016","journal-title":"Hear. Res."},{"issue":"1\u20132","key":"10.1016\/j.heares.2021.108202_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5955(97)00095-6","article-title":"Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig","volume":"111","author":"Stengs","year":"1997","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2021.108202_bib0031","doi-asserted-by":"crossref","first-page":"E2151","DOI":"10.1002\/hed.24026","article-title":"Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: a systematic review","volume":"38","author":"Strojan","year":"2016","journal-title":"Head Neck"}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595521000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595521000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:56:38Z","timestamp":1759920998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595521000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":29,"alternative-id":["S0378595521000368"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2021.108202","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinically derived guinea pig dosing model of cisplatin ototoxicity","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2021.108202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108202"}}